Janus Kinases (JAKs) | Kinases | Tocris Bioscience
JCI - JAK inhibitors in autoinflammation
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
IJMS | Free Full-Text | Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms | HTML
A MicroRNA-1–Mediated Inhibition of the NF-κB Pathway by the JAK-STAT Pathway in the Invertebrate Litopenaeus vannamei | The Journal of Immunology
Translational and clinical advances in JAK‐STAT biology: The present and future of jakinibs - Gadina - 2018 - Journal of Leukocyte Biology - Wiley Online Library
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Cells | Free Full-Text | Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy | HTML
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma - Journal of Hepatology
APExBIO - JAK/STAT Signaling - Signaling Pathways
Current and future status of JAK inhibitors - The Lancet
JAK/STAT signaling - My Cancer Genome
Ruxolitinib | CAS 941678-49-5 | InvivoGen
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors | PNAS
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology | Immunology
□ Janus激酶抑製劑的研究與開發 Research and Development of Janus Kinase (JAK) Inhibitors - 龍欣科技股份有限公司 EDRAGON TECHNOLOGY CORPORATION
JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
PathwayReady JAK/STAT Signaling Inhibitor Panel biochemical
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
:max_bytes(150000):strip_icc()/jak-inhibitors-4706526-FINAL-3461d4fc6ce44f54801ef59489afa62c.png "JAK Inhibitors: Uses, Drug Options, and Side Effects")
JAK Inhibitors: Uses, Drug Options, and Side Effects
JAK-STAT signaling pathway - Cusabio
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Signalling through the JAK–STAT pathway in the developing brain: Trends in Neurosciences
JAK inhibitors in dermatology: The promise of a new drug class - Journal of the American Academy of Dermatology
